Literature DB >> 28384742

How Would You Manage Opioid Use in These Three Patients?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Daniel P Alford, Marc L Cohen, Eileen E Reynolds.   

Abstract

The increase in overdose deaths from prescription opioids and heroin in the United States over the past 20 years is believed to have resulted from increases in prescription of opioids for management of acute and chronic pain. Managing chronic pain is challenging for primary care clinicians for many reasons, including the lack of evidence to guide practice. The Centers for Disease Control and Prevention published a comprehensive guideline in 2016 to help clinicians with opioid prescribing for chronic pain. In this Grand Rounds, the guideline is reviewed and an expert discusses its application to 3 patients prescribed opioids to treat chronic pain.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28384742     DOI: 10.7326/M17-0287

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  3 in total

1.  Utilizing a Faculty Development Program to Promote Safer Opioid Prescribing for Chronic Pain in Internal Medicine Resident Practices.

Authors:  Payel Roy; Angela H Jackson; Jeffrey Baxter; Belle Brett; Michael Winter; Ilana Hardesty; Daniel P Alford
Journal:  Pain Med       Date:  2019-04-01       Impact factor: 3.750

2.  Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.

Authors:  Isaac Chua; Athena K Petrides; Gordon D Schiff; Jaime R Ransohoff; Michalis Kantartjis; Jocelyn Streid; Christiana A Demetriou; Stacy E F Melanson
Journal:  J Gen Intern Med       Date:  2019-11-11       Impact factor: 5.128

3.  Comparing the efficacy of Morphine alone with Morphine and mgso4 in pain management after coronary artery bypass surgery.

Authors:  Rana Altaf Ahmad; Syed Suhail Ahmad; Waqas Hamid; Aamir Furqan
Journal:  Pak J Med Sci       Date:  2018 Mar-Apr       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.